Christine Siu has 12 years of experience in private equity and venture capital. She has worked with Third Rock Ventures, Warburg Pincus and Thomas McNerney, specializing in life sciences and biotechnology. Most recently, she started a company, Global Blood Therapeutics (GBT), with Third Rock Ventures. Christine currently consults with venture funds and start-up biotech companies in the field of corporate development, strategic planning, finance and operations. She holds a MBA from Harvard Business School and a BS in cellular molecular biology and economics from the University of Michigan.
Finance: This video series is designed to teach bench researchers how scientists in labs and corporations allocate financial resources. (Talk recorded in December 2016)
Audience:
Audience:
Audience:
